4/A//SEC Filing
SALIX PHARMACEUTICALS LTD 4/A
Accession 0001209191-14-018355
CIK 0001009356operating
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:44 PM ET
Size
10.5 KB
Accession
0001209191-14-018355
Insider Transaction Report
Form 4/AAmended
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
- Gift
Common Stock
2014-02-06−400,000→ 501,405.2 total - Gift
Common Stock
2014-02-06+400,000→ 400,000 total(indirect: By GRAT)
Holdings
- 44,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying) - 33,750
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-07-01→ Common Stock (33,750 underlying) - 65,625
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-07-01→ Common Stock (65,625 underlying)
Footnotes (2)
- [F1]Options are 100% vested.
- [F2]The reporting person's Form 4 filed February 19, 2014 mistakenly indicated the expiration date was 6/17/2014 when in fact the expiration date is 7/1/2014. The reporting person's expiration date reported herein reflects the correct information as of the date hereof.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:44 PM ET
- Size
- 10.5 KB